跳至主要内容
临床试验/NCT04146259
NCT04146259已完成不适用

Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism

University of Athens1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2017年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
109
试验地点
1
主要终点
change in circulating serum sclerostin levels (pmol/L) during the observation period

研究概览

简要总结

To investigate changes in sclerostin levels following acute post-thyroidectomy hypoparathyroidism

详细描述

Female patients with thyroid disorders, referred to the Department of Head and Neck Surgery, at Metaxa Anti-Cancer Hospital of Piraeus, for total thyroidectomy.

Based on the development of biochemical hypocalcemia (cCa < 8.4 mg/dl), subjects were divided into 2 groups: Group A: without postsurgical hypoparathyroidism that served as controls and group B: subjects, with acute postsurgical hypoparathyroidism.

Blood collections were performed in the morning after an overnight fast, in at least 3 different time points; preoperatively, 1st postoperative day and 7th postoperative day for the detrmination of sclerostin levels

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Indication for total thyroidectomy

排除标准

  • parathyroid disorders, chronic kidney disease (eGFR< 60 ml/min), treatment with antiosteoporosis drugs, rheumatic disease and history of long term (>1 month) or current corticosteroid use

研究组 & 干预措施

Group B

Post-surgical hypoparathyroidism

干预措施: calcium carbonate and alphacalcidol (Drug)

结局指标

主要结局

change in circulating serum sclerostin levels (pmol/L) during the observation period

时间窗: 7 days

change in circulating serum sclerostin levels (pmol/L)during the observation period

次要结局

  • the between groups difference in % changes of circulating sclerostin(7 days)

研究者

发起方
University of Athens
申办方类型
Other
责任方
Principal Investigator
主要研究者

Symeon tournis

Senior Research Fellow

University of Athens

研究点 (1)

Loading locations...

相似试验